Literature DB >> 8471616

Formation of DNA-protein cross-links in mammalian cells by levuglandin E2.

K K Murthi1, L R Friedman, N L Oleinick, R G Salomon.   

Abstract

Levuglandin E2 (LGE2), a rearrangement product derived from the prostaglandin endoperoxide, PGH2, causes repair-resistant DNA-protein cross-links and cell death (LD50 = 230 nM) in V79 Chinese hamster lung fibroblasts. The half-life for sequestration of LGE2 by covalent binding to cellular nucleophiles is at least an hour for 10 microM LG. This suggests that the in vivo production and distribution of free LGs should be measurable on this time scale. Following removal of the LGE2 and the return of the cultures to normal growth medium, additional DNA-protein cross-links continued to form over the ensuing 6-24 h. The results suggest that LG adducts to DNA or protein are not repaired, but react further at sites on protein or DNA in close proximity to the initial adducts, forming cross-links in a slow phase of the process.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471616     DOI: 10.1021/bi00066a034

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

1.  Total Synthesis Confirms the Molecular Structure Proposed for Oxidized Levuglandin D2.

Authors:  Yu-Shiuan Cheng; Wenyuan Yu; Yunfeng Xu; Robert G Salomon
Journal:  J Nat Prod       Date:  2017-02-14       Impact factor: 4.050

Review 2.  Covalent modification of biological targets with natural products through Paal-Knorr pyrrole formation.

Authors:  Alexander Kornienko; James J La Clair
Journal:  Nat Prod Rep       Date:  2017-08-30       Impact factor: 13.423

3.  Isolevuglandins as a gauge of lipid peroxidation in human tumors.

Authors:  H P Yan; L J Roberts; S S Davies; P Pohlmann; F F Parl; S Estes; J Maeng; B Parker; R Mernaugh
Journal:  Free Radic Biol Med       Date:  2017-02-09       Impact factor: 7.376

4.  Molecular Structures of Isolevuglandin-Protein Cross-Links.

Authors:  Wenzhao Bi; Geeng-Fu Jang; Lei Zhang; John W Crabb; James Laird; Mikhail Linetsky; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2016-09-21       Impact factor: 3.739

Review 5.  Isolevuglandin adducts in disease.

Authors:  Robert G Salomon; Wenzhao Bi
Journal:  Antioxid Redox Signal       Date:  2015-02-18       Impact factor: 8.401

Review 6.  Mechanisms of isolevuglandin-protein adduct formation in inflammation and hypertension.

Authors:  Liang Xiao; David M Patrick; Luul A Aden; Annet Kirabo
Journal:  Prostaglandins Other Lipid Mediat       Date:  2018-09-29       Impact factor: 3.072

7.  Formation of gamma-ketoaldehyde-protein adducts during ethanol-induced liver injury in mice.

Authors:  Sanjoy Roychowdhury; Megan R McMullen; Michele T Pritchard; Wei Li; Robert G Salomon; Laura E Nagy
Journal:  Free Radic Biol Med       Date:  2009-07-17       Impact factor: 7.376

8.  Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts.

Authors:  Wei Li; James M Laird; Liang Lu; Sanjoy Roychowdhury; Laura E Nagy; Rong Zhou; John W Crabb; Robert G Salomon
Journal:  Free Radic Biol Med       Date:  2009-09-12       Impact factor: 7.376

9.  Comparative study of HOCl-inflicted damage to bacterial DNA ex vivo and within cells.

Authors:  Christine Suquet; Jeffrey J Warren; Nimulrith Seth; James K Hurst
Journal:  Arch Biochem Biophys       Date:  2009-10-20       Impact factor: 4.013

10.  Characterization of covalent adducts of nucleosides and DNA formed by reaction with levuglandin.

Authors:  Erica J Carrier; Venkataraman Amarnath; John A Oates; Olivier Boutaud
Journal:  Biochemistry       Date:  2009-11-17       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.